NCT06808321View on ClinicalTrials.gov

Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients

Enrolling by invitationOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

June 1, 2026

Conditions
Chronic Coronary SyndromeHypertensionAngina Pectoris
Interventions
DRUG

Benidipine Hydrochloride

The safety and efficacy of a dihydropyridine calcium channel blocker for the treatment of high blood pressure and/or angina pectoris

Trial Locations (1)

Unknown

Antalya Kepez State Hospital, Antalya

All Listed Sponsors
lead

The Society of Prevention and Awareness of Cardiovascular Diseases

OTHER